Amipharma Laboratories Ltd is a private family owned pharmaceutical company, a subsidiary of Elamin Hamid group, specializing in the manufacture and sale of pharmaceutical products. Amipharma was established in 1975, started its first production in 1983. Amipharma occupies a total area of 58,000.m2 with roofed area of 28,600m2.
1983 Amipharma started its first production
Beesham UK certified under license producer
1986 Amipharma received the Unido Award
1989 Good Performance Star from Head of State
1997 Liquid lines were introduced to our range
2000 Major rehabilitation for the whole manufacturing area, Quality Control and stores took place to comply with the new international regulations.
2001 Order of Merit from the president of Sudan
2002 First pharmaceutical company to be awarded the ISO 9001:2000 GMP certification from Eritrean Drug Control, and started exporting to Eritrea
2010 Certificate of Merit from the ARAB UNION OF PHAMACEUTICAL MANUFACTURERS ASSOCIATION Golden medal of Science and Technology Award from the president
2013 Golden Certificate of Merit for the CEO in his contribution in Science & Technology. 2013 GMP certification from the Republic of Chad
2014 GMP certificate from Kenyan Drug Authority.
2016 Order of honor from the Arabic Pharmaceutical Union in their golden 50th Anniversary
WHO WE ARE
VISION & MISSION
We strive towards better health for patients in our country and neighboring African countries, through developing and manufacturing a wide range of pharmaceutical products that comply with the highest regulatory standards to satisfy the needs of our community and the neighboring countries.
To be the leader in generic pharmaceutical sector in Sudan and in the neighboring African countries.
Amipharma adopted an organizational culture and different way of thinking that has evolved through the company’s history. Those core values govern all our activities in producing “High Quality Products at Affordable Prices”, emphasizing the principles of Amipharma in improving healthcare for all.
Amipharma believes in and hold the following values at the core of it’s buisiness
- Quality is everyone’s concern.
- We conduct ourselves with Fairness, Trust, Honesty, Integrity and Respect.
- We encourage team work, participative decision making, transparency and open communications.
- We have a great concern for the Society and Environment
- We ensure Ethical and Fair treatment to all our stakeholders.
Amipharma showed a very steady growth in both capital turnover and product range throughout its 30 years of operations. The authorized capital is 85 million USD and an annual turnover of more than 60 million USD (2014). Amipharma captured over 40% of total Sudanese pharmaceutical market share. Amipharma currently produce 80 products to the market and over 38 products in the pipeline for registration.
The key factor in Amipharma’s success is in re-investing a considerable amount of their profit each year in the business. These profits are used to continuously upgrade our facilities, acquiring new and advanced equipment and machines, utilities and continuously investing in our human resources through providing the necessary training in all fields of the business, both locally and abroad to upgrade their skills and knowledge.